This workshops aims to shed light on both new developments and old challenges in the field of antibiotics discovery and developing them into efficient medicine in a world increasingly challenged by antibiotics resistance. It starts off with talks from Prof. Andriy Luzhetskyy (Univ. of Saarbrücken, Germany), Prof. Marnix Medema (Univ. of Wageningen, Netherlands) and Dr. David Mead (Varigen Biosciences Corp., USA), three international experts within their respective field of research who will tell us about their innovative approaches in discovering new antibiotics. Dr. Bert Klebl will then talk about his efforts at the Lead Discovery Centre in Dortmund, Germany, to bridge the gap between academia and industry. In the afternoon we will focus on important societal aspects of antibiotics use and needs with speakers from The Norwegian Biotechnology Advisory Board, The Norwegian Cancer Society, Ung Kreft, The Norwegian Institute of Public Health and The Association of the Pharmaceutical Industry in Norway.
The workshop will take place at Scandic Lerkendal in Trondheim from 9:00 to 16:00, and is free of charge for the participants.
Dr. Christine Årdal, senior Advisor at the Norwegian Institute of Public Health in the Department of Antibiotic resistance and infection prevention. Christine Årdal has co-lead of the R&D workpackage in EU-JAMRAI (Joint Action on Antimicrobial Resistance and Healthcare-Aassociated Infections), and will talk about suggested incentives to increase antibiotic discovery and development in a Europe.
Download her presentation here